Financials

  • Market Capitalization 448.58 M
  • Employee 389
  • Founded 1999
  • CEO N/A
  • Website www.standardbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000S8WQB6
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-6.4
주가매출액비율
5.73

Standard BioTools Inc. - Common Stock

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.

뉴스